573 related articles for article (PubMed ID: 27321771)
1. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.
Tan KX; Danquah MK; Sidhu A; Lau SY; Ongkudon CM
Biotechnol Prog; 2018 Jan; 34(1):249-261. PubMed ID: 28699244
[TBL] [Abstract][Full Text] [Related]
3. Process evaluation and in vitro selectivity analysis of aptamer-drug polymeric formulation for targeted pharmaceutical delivery.
Tan KX; Lau SY; Danquah MK
Biomed Pharmacother; 2018 May; 101():996-1002. PubMed ID: 29635910
[TBL] [Abstract][Full Text] [Related]
4. Towards targeted cancer therapy: Aptamer or oncolytic virus?
Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY
Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990
[TBL] [Abstract][Full Text] [Related]
5. Binding Characterization of Aptamer-Drug Layered Microformulations and In Vitro Release Assessment.
Tan KX; Danquah MK; Pan S; Yon LS
J Pharm Sci; 2019 Sep; 108(9):2934-2941. PubMed ID: 31002808
[TBL] [Abstract][Full Text] [Related]
6. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
7. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Engineering of Aptamer-Drug Conjugates for Targeted Cancer Therapy.
Deng Z; Yang Q; Peng Y; He J; Xu S; Wang D; Peng T; Wang R; Wang XQ; Tan W
Bioconjug Chem; 2020 Jan; 31(1):37-42. PubMed ID: 31815437
[TBL] [Abstract][Full Text] [Related]
9. Engineering polymeric aptamers for selective cytotoxicity.
Yang L; Meng L; Zhang X; Chen Y; Zhu G; Liu H; Xiong X; Sefah K; Tan W
J Am Chem Soc; 2011 Aug; 133(34):13380-6. PubMed ID: 21702469
[TBL] [Abstract][Full Text] [Related]
10. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Xu G; Yu X; Zhang J; Sheng Y; Liu G; Tao W; Mei L
Int J Nanomedicine; 2016; 11():2953-65. PubMed ID: 27382282
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
12. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-based liposomes improve specific drug loading and release.
Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable polymers for targeted delivery of anti-cancer drugs.
Doppalapudi S; Jain A; Domb AJ; Khan W
Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
[TBL] [Abstract][Full Text] [Related]
15. 'Smart' delivery systems for biomolecular therapeutics.
Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
[TBL] [Abstract][Full Text] [Related]
16. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Delivery.
Yang L; Sun H; Liu Y; Hou W; Yang Y; Cai R; Cui C; Zhang P; Pan X; Li X; Li L; Sumerlin BS; Tan W
Angew Chem Int Ed Engl; 2018 Dec; 57(52):17048-17052. PubMed ID: 30387923
[TBL] [Abstract][Full Text] [Related]
18. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
19. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
